Gene · 5170
Papers2,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging roles of RNA N5-methylcytosine modification in reproductive physiology and gynecological diseases. | Epigenetics | 2026 | 41778387 | PubTator, text mining | PubMed |
| Diabetes mellitus is associated with an increased risk of postoperative neurocognitive disorders: a systematic review. | Front Med (Lausanne) | 2026 | 41767506 | PubTator, text mining | PubMed |
| Learning heritable multimodal brain representation via contrastive learning. | bioRxiv | 2026 | 41756892 | PubTator, text mining | PubMed |
| Lipid Metabolism Reprogramming in Diffuse Large B-Cell Lymphoma (DLBCL): Mechanisms and Treatment Strategies. | Cancers (Basel) | 2026 | 41749954 | PubTator, text mining | PubMed |
| Alternative methods for pharmacological research on the action mechanisms of natural products used in the treatment of type 2 diabetes: a systematic review. | Front Pharmacol | 2026 | 41743124 | PubTator, text mining | PubMed |
| STOML2 promotes hepatocellular carcinoma cell proliferation, invasion and migration by activating the PI3K/AKT signaling pathway (Review). | Oncol Lett | 2026 | 41743019 | PubTator, text mining | PubMed |
| Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis. | Ann Med | 2026 | 41741334 | PubTator, text mining | PubMed |
| Bioinformatic Screening of Key Regulatory Molecules and Mechanisms in Osteoporosis Based on Tryptophan Metabolism-Related Genes. | Int J Gen Med | 2026 | 41737536 | PubTator, text mining | PubMed |
| Mothers against decapentaplegic homolog 4 as a proteomic hub in vascular remodeling and residual cardiovascular risk. | World J Cardiol | 2026 | 41694032 | PubTator, text mining | PubMed |
| Preliminary study of cyto-impedance: Molecular profiling of functional impedance in motility-promoting treatment of normal cells. | Biochem Biophys Rep | 2026 | 41685087 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| Patient-derived lung organoids from bronchoalveolar lavage capture epithelial heterogeneity and disease biology in bronchopulmonary dysplasia. | Redox Biol | 2026 | 41621243 | PubTator, text mining | PubMed |
| Acetylcholine enhances HIF-1α signaling in pancreatic cancer cells under hypoxia through the nAChR-α7/PDPK1/YAP pathway. | Int J Biol Sci | 2026 | 41608625 | PubTator, text mining | PubMed |
| Novel stem cell therapy for cerebral palsy using stem cells from human exfoliated deciduous teeth. | Stem Cell Res Ther | 2026 | 41578408 | PubTator, text mining | PubMed |
| Triptolide in renal disorders: dual roles of therapeutic potential and nephrotoxicity: a narrative review. | Pharm Biol | 2026 | 41562626 | PubTator, text mining | PubMed |
| Gallic acid-conjugated 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone induces apoptosis and downregulates PI3K/Akt signaling through VEGFR-2 targeting in non-small cell lung cancer (NSCLC). | Biomed Pharmacother | 2026 | 41496366 | PubTator, text mining | PubMed |
| Network toxicology and machine learning reveal key molecular targets and pathways of mono-2-ethylhexyl phthalate-induced atherosclerosis. | Drug Chem Toxicol | 2026 | 41250617 | PubTator, text mining | PubMed |
| USP22 promotes neuroblastoma growth, metastasis, and glycolysis via mediating the deubiquitination of PDK1. | J Neuropathol Exp Neurol | 2026 | 40694818 | PubTator, text mining | PubMed |
| Bridging tradition and innovation: electroacupuncture's impact on premature ovarian insufficiency. | Front Endocrinol (Lausanne) | 2025 | 41799227 | PubTator, text mining | PubMed |
| Rational design of next-generation PDK1 modulators: Addressing selectivity and resistance through molecular insights - A medicinal chemistry perspective. | Bioorg Chem | 2025 | 41270611 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5170/papers?page=2